- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00679562
Lactacyd Radiance (Lactic Acid) Prophetic Patch Test
February 5, 2009 updated by: Sanofi
Skin Irritation : Prophetic Patch Test of Lactacyd Radiance
Primay objective:
To evaluate the potential of the products in eliciting adverse skin reaction.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bangkok, Thailand
- Sanofi-Aventis Administrative Office
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Test area should have a healthy or normal skin
- Individuals free of any systemic or dermatological disorder which, in the opinion of the investigative personnel would interfere with the study results or increase the risk of adverse reaction
- Not currently use of steroid or any medication during the test
Exclusion Criteria:
History of Allergy or Allergic Reaction to:
- Hey Fever
- Asthma
- Poison Ivy
- Food
- Cosmetics
- Soap
- Detergent
- Metal
- Jewelry
- Lather
- Fabric
- Medication
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
|
Application of occlusive patches containing test product.
For 24 hours and repeat 2 weeks later for participants with no reaction to Lactacyd Radiance
Other Names:
|
Placebo Comparator: 2
|
Application of patches containing distilled water for 24 hours
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Reaction after patch removal.
Time Frame: at 15-30 minutes and day 3
|
at 15-30 minutes and day 3
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Taweeporn NATESUMROENG, Sanofi
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2008
Primary Completion (Actual)
April 1, 2008
Study Registration Dates
First Submitted
May 15, 2008
First Submitted That Met QC Criteria
May 15, 2008
First Posted (Estimate)
May 19, 2008
Study Record Updates
Last Update Posted (Estimate)
February 6, 2009
Last Update Submitted That Met QC Criteria
February 5, 2009
Last Verified
February 1, 2009
More Information
Terms related to this study
Other Study ID Numbers
- LACAC_L_03648
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hygiene
-
SanofiCompleted
-
SanofiCompleted
-
SanofiCompleted
-
University of WarwickCompleted
Clinical Trials on Lactic Acid
-
Microbio Co LtdNot yet recruitingStaphylococcus Aureus | Atopic Dermatitis
-
Galderma R&DCompletedWrinkles in DecolletageUnited States
-
Bausch Health Americas, Inc.Completed
-
Galderma Brasil Ltda.Completed
-
Herlev HospitalCompleted
-
Bausch Health Americas, Inc.Completed
-
Bausch Health Americas, Inc.CompletedFacial LipoatrophyUnited States
-
Microbio Co LtdNot yet recruiting
-
Bausch Health Americas, Inc.CompletedNasolabial Fold WrinklesUnited States
-
Bausch Health Americas, Inc.CompletedNasolabial Fold WrinklesUnited States